Good news doesn't travel to every corner. The overall market rose yet again, but shareholders of three health-care stocks are certainly not singing a happy tune after the past week.
One of the big losers could just be experiencing the effects of profit-taking after a huge stock run-up. Another felt the sting of an analyst report citing concerns about a clinical study in progress. Yet another absorbed the impact of announcing a big secondary offering that dilutes existing shareholders' stock value.
Which stocks were crushed badly by the market this week? Find out by watching the following slideshow.
Keith Speights has no position in any stocks mentioned. The Motley Fool recommends Vertex Pharmaceuticals. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.